About Dylas Pharmaceuticals Private Limited
Data last updated:
Dylas Pharmaceuticals Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2012PTC054022. Its GSTIN is 09AAECD4793J1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Dhruv Narayan Singh (Managing Director) and Parakh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C4/33 Sarai Gobardhan Chetganj, Varanasi, Uttar Pradesh, India – 221001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.02 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹28,112 (net margin 0.3%) and EBITDA of ₹57,120 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dylaspharma.com.
Company details
Contact details
Dylas Pharmaceuticals Private Limited's registered office is in Varanasi, Uttar Pradesh. Its website is dylaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC4/33 Sarai Gobardhan Chetganj, Varanasi, Uttar Pradesh, India – 221001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dylas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dylas Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dylas Pharmaceuticals Private Limited, buy the company report.
Financials of Dylas Pharmaceuticals Private Limited
FY 2025 filings availableDylas Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr (down 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 13% fall in the latest year. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57,120 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,112 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dylas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dylas Pharmaceuticals Private Limited
Dylas Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhruv Narayan Singh | Managing Director | 07 Dec 2012 | 13 Years 10 Months | Current |
| Parakh | Director | 18 Aug 2015 | 11 Years 2 Months | Current |
Auditor
Dylas Pharmaceuticals Private Limited is audited by VIDISHA TIWARI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIDISHA TIWARI & ASSOCIATES | FY 2017 | 017734C |
Shareholding
The shareholding of Dylas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dylas Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dylas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dylas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dylas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECD4793J1Z6 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dylas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dylas Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Lal Bahadur Singh ceased to be Whole-Time Director on 25 Apr 2021.
Frequently asked questions
Dylas Pharmaceuticals is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 December 2012 (14+ years old) and is registered under CIN U74120UP2012PTC054022.
Dylas Pharmaceuticals has 2 current directors:
- Dhruv Narayan Singh - Managing Director
- Parakh - Director
The latest financial statements of Dylas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dylas Pharmaceuticals is 09AAECD4793J1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dylas Pharmaceuticals is U74120UP2012PTC054022. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dylas Pharmaceuticals was incorporated on 07 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.
Lal Bahadur Singh ceased to be Whole-Time Director on 25 Apr 2021. Parakh was appointed as Director on 18 Aug 2015. Ashwini Kumar Singh ceased to be Director on 20 Jul 2015. Dylas Pharmaceuticals has 4 board changes on record in total.
Dylas Pharmaceuticals can be reached through the website dylaspharma.com. Its registered office is in Varanasi, Uttar Pradesh, India.
The registered office of Dylas Pharmaceuticals is at C433 Sarai Gobardhan Chetganj, Varanasi, Uttar Pradesh, India – 221001.
Dylas Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
